MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Loss of paraplegin drives spasticity rather than ataxia in SPG7: A European cohort analysis of 238 patients

    G. Coarelli, R. Schule, B. vande Warrenburg, P. de Jonghe, C. Ewenczyk, A. Martinuzzi, M. Synofzik, E. Hamer, J. Baets, M. Anheim, L. Schöls, T. Deconinck, B. Fontaine, T. Klockgether, MG. D'Angelo, ML. Monin, P. Charles, MT. Bassi, T. Klopstock, E. Ollagnon-Roman, C. Kamm, M. Papin, CS. Davoine, G. Banneau, S. Tezenasdu Montcel, D. Seilhean, A. Brice, C. Duyckaerts, G. Stevanin, A. Durr (Paris, France)

    Objective: The aim of this work was to delineate the clinical phenotype of SPG7 patients, integrating genetic data and follow-up examinations, taking advantage of a…
  • 2018 International Congress

    Cerebellar Ataxia as a Manifestation of Hashimoto Encephalopathy

    S. Thakolwiboon, D. Ruthirago, V. Senanarong (Lubbock, TX, USA)

    Objective: To characterize the clinical, laboratory and radiologic findings as well as prognosis of Hashimoto encephalopathy (HE) presenting with cerebellar ataxia Background: HE is a…
  • 2018 International Congress

    Treatment with docosahexaenoic acid in Spinocerebellar Ataxia 38

    D. Perani, L. Orsi, C. Costanzi, M. Ferrero, A. Zoppo, F. Tempia, D. Caruso, M. Grassi, A. Padovani, A. Brusco, B. Borroni (Brescia, Italy)

    Objective: To evaluate the safety and efficacy of docosahexaenoic acid supplementation in patients with spinocerebellar ataxia 38 (SCA 38), on clinical symptoms and changes of…
  • 2018 International Congress

    Generalized chorea in a patient with isolated leukocytosis and JAK2V617F mutation: A case report

    S. Bette, H. Moore, C. Singer (Miami, FL, USA)

    Objective: To describe late-onset generalized chorea in a patient found to have the JAK2V617F mutation without polycythemia vera. Background: Polycythemia vera (PV) is well-known to…
  • 2018 International Congress

    Acute concomitant presentation of chorea and subacute combined degeneration secondary to vitamin B12 deficiency

    E. Natera, F. Acebrón, A. Sánchez, V. Ros, A. Gómez, F. Ruiz, B. Zarza, C. Estévez, A. Alonso, JC. Martínez-Castrillo, I. Corral (Madrid, Spain)

    Objective: To describe an exceptional presentation of vitamin B12 deficiency. Background: Vitamin B12 deficiency typically presents with subacute combined degeneration (SCD). Extrapyramidal symptoms are rare,…
  • 2018 International Congress

    Phenotypic Heterogeneity and Variability of Nigrostriatal Dopaminergic Function in a Dopa-Responsive Dystonia

    J.J. Lin (Nantou, Taiwan)

    Objective: To evaluate presynaptic nigrostriatal dopaminergic function in a Dopa-responsive dystonia (DRD) family with guanosine triphosphate cyclohydrolase 1 (GCH-1) mutation. Background: Mutation of GCH-1 located…
  • 2018 International Congress

    Higher self-rated obsessive-compulsion in functional compared with organic dystonia

    R. Newby, J. Alty, S. Jamieson, S. Smith, P. Kempster (Leeds, United Kingdom)

    Objective: To evaluate obsessive-compulsive symptomatology in functional and organic dystonia Background: Case-control studies have reported elevated rates of obsessive-compulsion in genetic (DYT11 and DYT5) and…
  • 2018 International Congress

    Zolpidem effect in task specific dystonia – clinical and neurophysiological study

    K. Vogelnik, M. Grmek, R. Perellon Alfonso, P. Tomše, M. Trošt, M. Kojović (Ljubljana, Slovenia)

    Objective: We conducted a double blind, placebo-controlled crossover study to examine clinical and neurophysiological effect of zolpidem in patients with task specific dystonia. Background: Task…
  • 2018 International Congress

    Movement and postural control in focal dystonia subjects measured using surface electromyography

    F. Chang, S. Babu, S. Kim, N. Mahant, O. Vucic, V. Fung (Wentworthville, Australia)

    Objective: To explore the difference in muscle activation during a postural versus movement control task in patients with focal dystonia. Background: Co-contraction of agonist and…
  • 2018 International Congress

    Disease Modeling of Lesch-Nyhan Disease Using Induced Pluripotent Stem Cells

    D. Sutcliffe, A. Dinasarapu, M. Zwick, H. Jinnah (Atlanta, GA, USA)

    Objective: To create a resource of induced pluripotent stem cells (iPSCs) as models for exploring mechanisms of pathogenesis in Lesch-Nyhan disease (LND). Background: LND is…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley